Other covariates examined, including sex, HIV status, gestational age, concomitant medication, albumin concentrations, study (BEAT Tuberculosis vs KDH study), and study sites had no significant effect on the pharmacokinetics of levofloxacin. The gene discussed is ALB; the disease is tuberculosis.